Blogs
– My instinctive reaction to Monday’s tragic news was to not write a positive news blog this week. But why let the terrorists win? Dry Bones’ cartoon included...
Hi, what are you looking for?
– My instinctive reaction to Monday’s tragic news was to not write a positive news blog this week. But why let the terrorists win? Dry Bones’ cartoon included...
– The month of July will adversely affect everybody’s financial assets; and we may also expect a number of companies, banks and major world...
– VBL is developing drugs for the treatment of cancer and inflammatory diseases. On Friday, VBL Therapeutics Ltd. (formerly Vascular Biogenics) published a draft prospectus...
– Berg has devoted considerable time, energy as well as capital in his latest venture, Berg Pharma in the search for new treatments for...
– Weizmann Institute researchers discover that a “standoff” between a mutated gene and its normal counterpart keeps certain cancer cells alive. – Leukemia Cells...
– AstraZeneca plc (LSE; NYSE: AZN) and Hadasit, the commercial arm and technology transfer company of Israel’s Hadassah University Hospitals, announced today they will...
– Dr. Larisch, of the University of Haifa, has been involved in the study of a specific protein capable of destroying cancer stem cells...
– The company has failed to find a partner for the further development and commercialization of its lead product, BC-819. – – Biocancell...
– This approval provides the regulatory framework for the commercialization of Lonquex in all 28 EU countries. – Illustration Teva Pharmaceutical Industries Ltd...
– Apoptosis – /By Alan Gallindoss / Apotex has developed new molecular-level imaging technology to detect diseases within human cells, and potentially help therapeutically...